Indo Amines Limited (INDOAMIN)

Chemicals · Chemicals & Petrochemicals · NSE · Updated 15 July 2026
₹137.95 ↓ 14.95% (1Y)

🎯 Key Takeaways

  • Indo Amines Limited is navigating a transitional phase marked by governance updates and modest financial performance, with revenue trends showing signs of stabilization after a peak in FY23. The company maintains a mid-sized footprint in the specialty amines segment, but growth has plateaued, reflected in a 14.
  • Revenue declined 3.9% QoQ to ₹259 in Q3FY25.
  • ⚠️ Margin compression is emerging, with OPM declining consistently over the past four quarters despite revenue stabilization, potentially signaling prici
Market Cap
₹925
P/E Ratio
17.0
Div Yield
0.00%
Promoter
0.0%

📖 The Story

Indo Amines Limited is navigating a transitional phase marked by governance updates and modest financial performance, with revenue trends showing signs of stabilization after a peak in FY23. The company maintains a mid-sized footprint in the specialty amines segment, but growth has plateaued, reflected in a 14.95% one-year return and a P/E of 17.0. Management has focused on board-level changes and compliance rather than aggressive expansion, suggesting a conservative operational stance.

📰 What's Happening

Recent board actions include the appointment of Rahul Chitnis as an Additional Independent Director pending shareholder approval, effective 15 July 2026, and the resignation of Independent Director Vijay Yeshwant Sane effective 16 April 2026, both disclosed via regulatory filings. Shareholders approved the re-appointment of Whole-Time Director Mrs. Bharati Palkar for three years and remuneration increases for key managerial personnel, including Managing Director Vijay Palkar and Joint Managing Director Rahul Palkar, via postal ballot results to be announced by 17 July 2026. These governance moves underscore continuity in leadership but require formal ratification, introducing a short-term procedural delay.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricQ4FY23Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25
Revenue235244253194253265269259
Operating Profit3326262222352927
OPM %13.2%8.9%8.0%10.3%6.9%10.4%8.9%9.4%
Net Profit171212109191411
EPS₹2.44₹1.66₹1.75₹1.30₹1.32₹2.70₹1.96₹1.52

Quarterly revenue has shown mixed movement, peaking at ₹269 crore in Q2FY25 before declining to ₹259 crore in Q3FY25, indicating stabilization after earlier growth. Operating performance has softened, with OPM declining from a high of 13.2% in Q4FY23 to 9.4% in Q3FY25, suggesting margin pressure despite flat revenue trends. Net profit and EPS have also trended downward from ₹17 crore and ₹2.44 in Q4FY23 to ₹11 crore and ₹1.52 in Q3FY25, reflecting the impact of reduced operational efficiency and possibly higher input costs or pricing pressure in the current cycle.

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance on revenue or margin expectations in the latest filings, with no commentary attached to the most recent financial results or board meeting announcements. The absence of strategic updates or growth projections implies a cautious stance, with focus instead on governance compliance and director appointments. Any future outlook will likely be communicated during the next earnings call or investor presentation, pending shareholder approval of recent board changes.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Chemicals & Petrochemicals

Company MCap (₹ Cr) P/E ROCE ROE D/E
Solar Industries India Limited 1.57 L Cr 132.3
Pidilite Industries Limited 1.49 L Cr 75.7
SRF Limited 79,723 69.5
Linde India Limited 62,701 141.9
Gujarat Fluorochemicals Limited 40,793 89.6
Navin Fluorine International Limited 35,894 131.5
Himadri Speciality Chemical Limited 30,071 56.6
Deepak Nitrite Limited 24,911 33.3
Atul Limited 20,904 48.8
Tata Chemicals Limited 19,079 -47.1

⚠️ Risk Factors

1. Margin compression is emerging, with OPM declining consistently over the past four quarters despite revenue stabilization, potentially signaling pricing pressure or rising input costs. 2. Governance volatility persists due to recent director resignations and pending shareholder approvals for key appointments, which could delay decision-making. 3. No visible growth catalysts are evident in the filings, raising concerns about long-term top-line expansion in a competitive chemicals market.

📋 Recent Filings

🧠 Analyst's Read

Indo Amines is currently in a stabilization phase with governance updates taking precedence over financial momentum. Investors should monitor the upcoming shareholder voting results for director appointments and any future commentary on operational outlook, as the company appears to be in a holding pattern without a clear growth narrative yet.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.

📡 Get AI alerts when INDOAMIN files new disclosures

Track INDOAMIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track INDOAMIN — Free

Free account · 2 AI queries/day